Medclick Pharma

Geftib 250mg tablets contain Gefitinib, a targeted cancer therapy used to treat certain types of non-small cell lung cancer (NSCLC). Gefitinib is an EGFR inhibitor that blocks signals responsible for cancer cell growth and division. It is most effective in patients whose cancer cells have specific EGFR gene mutations.

Iressa 250mg is a prescription medication containing Gefitinib, a targeted therapy for non-small cell lung cancer (NSCLC). Gefitinib is part of a class of cancer medicines known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. It is specifically effective in patients whose lung cancer cells have activating mutations in the EGFR gene, which promote abnormal cell growth.

Geftinat 250mg tablets contain Gefitinib, an oral targeted therapy used in the treatment of non-small cell lung cancer (NSCLC). Gefitinib is a type of drug known as an EGFR tyrosine kinase inhibitor, which is specifically designed to block abnormal signaling in cancer cells with EGFR gene mutations—a common driver of certain lung cancers.

Gefticip 250mg tablets contain Gefitinib, a targeted cancer therapy that belongs to a class of drugs known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. It is used to treat specific forms of non-small cell lung cancer (NSCLC) in patients whose tumors show EGFR mutations. Gefitinib blocks the signals that cancer cells use to grow and divide, making it especially effective in genetically selected patients.